303 related articles for article (PubMed ID: 31314805)
21. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
23. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
24. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte Growth Factor Secreted from Human Adipose-Derived Stem Cells Inhibits Fibrosis in Hypertrophic Scar Fibroblasts.
Ma J; Yan X; Lin Y; Tan Q
Curr Mol Med; 2020; 20(7):558-571. PubMed ID: 31903876
[TBL] [Abstract][Full Text] [Related]
26. Adipose-Derived Stem Cell-Enriched Lipotransfer Reverses Skin Sclerosis by Suppressing Dermal Inflammation.
Jiang W; Wang J; Lin J; Jiang S; Quan Y; Liao Y; Gao J; Cai J
Plast Reconstr Surg; 2022 Sep; 150(3):578-587. PubMed ID: 35759642
[TBL] [Abstract][Full Text] [Related]
27. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
[TBL] [Abstract][Full Text] [Related]
28. 2-Methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase/Akt/mTOR signalling.
Zhou X; Liu C; Lu J; Zhu L; Li M
Rheumatology (Oxford); 2018 Sep; 57(9):1675-1684. PubMed ID: 29905853
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
30. Hypothesis: pathogenesis of systemic sclerosis.
Takehara K
J Rheumatol; 2003 Apr; 30(4):755-9. PubMed ID: 12672195
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
32. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
[TBL] [Abstract][Full Text] [Related]
33. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Abraham D
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
[TBL] [Abstract][Full Text] [Related]
34. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
Dufour AM; Alvarez M; Russo B; Chizzolini C
Front Immunol; 2018; 9():1865. PubMed ID: 30150989
[TBL] [Abstract][Full Text] [Related]
37. PDGF Promotes Dermal Fibroblast Activation
Takamura N; Renaud L; da Silveira WA; Feghali-Bostwick C
Front Immunol; 2021; 12():745308. PubMed ID: 34912333
[TBL] [Abstract][Full Text] [Related]
38. Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis.
Higuchi T; Kawaguchi Y; Takagi K; Tochimoto A; Ota Y; Katsumata Y; Ichida H; Hanaoka M; Kawasumi H; Tochihara M; Yamanaka H
Clin Immunol; 2015 Dec; 161(2):333-8. PubMed ID: 26387628
[TBL] [Abstract][Full Text] [Related]
39. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis.
Rozier P; Maumus M; Bony C; Maria ATJ; Sabatier F; Jorgensen C; Guilpain P; Noël D
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
